Literature DB >> 11242036

Involvement of chemokine receptors in breast cancer metastasis.

A Müller1, B Homey, H Soto, N Ge, D Catron, M E Buchanan, T McClanahan, E Murphy, W Yuan, S N Wagner, J L Barrera, A Mohar, E Verástegui, A Zlotnik.   

Abstract

Breast cancer is characterized by a distinct metastatic pattern involving the regional lymph nodes, bone marrow, lung and liver. Tumour cell migration and metastasis share many similarities with leukocyte trafficking, which is critically regulated by chemokines and their receptors. Here we report that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases. Their respective ligands CXCL12/SDF-1alpha and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis. In breast cancer cells, signalling through CXCR4 or CCR7 mediates actin polymerization and pseudopodia formation, and subsequently induces chemotactic and invasive responses. In vivo, neutralizing the interactions of CXCL12/CXCR4 significantly impairs metastasis of breast cancer cells to regional lymph nodes and lung. Malignant melanoma, which has a similar metastatic pattern as breast cancer but also a high incidence of skin metastases, shows high expression levels of CCR10 in addition to CXCR4 and CCR7. Our findings indicate that chemokines and their receptors have a critical role in determining the metastatic destination of tumour cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242036     DOI: 10.1038/35065016

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1752 in total

1.  Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.

Authors:  Mina J Bissell; Johanne Le Beyec; Robin L Anderson
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

Review 2.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.

Authors:  C Chang; Z Werb
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

3.  Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles.

Authors:  K Red-Horse; P M Drake; M D Gunn; S J Fisher
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 4.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 5.  Chemokine expression and function at the human maternal-fetal interface.

Authors:  Penelope M Drake; Kristy Red-Horse; Susan J Fisher
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 6.  Getting to the guts of immune regulation.

Authors:  Janine Bilsborough; Joanne L Viney
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

7.  Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties.

Authors:  Janine Bilsborough; Thaddeus C George; Anne Norment; Joanne L Viney
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

8.  In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.

Authors:  Wojciech G Lesniak; Teshome Aboye; Samit Chatterjee; Julio A Camarero; Sridhar Nimmagadda
Journal:  Chemistry       Date:  2017-08-03       Impact factor: 5.236

9.  A case of sigmoid colon adenocarcinoma diagnosed as facial cutaneous metastasis for survival after operation for 37 months.

Authors:  Junji Ueda; Hiroshi Yoshida; Hiroshi Makino; Hiroshi Maruyama; Tadashi Yokoyama; Atsushi Hirakata; Hideyuki Takata; Natsuki Seki; Yuta Kikuchi; Eiji Uchida
Journal:  Clin J Gastroenterol       Date:  2017-08-03

Review 10.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.